Abstract
Hypoxia-inducible factor (HIF)-1alpha, a global regulator of oxygen homeostasis, plays a crucial role in tumor cell adaptation to the hypoxic microenvironment through transcriptional regulation of its target genes. These genes in turn are involved in a plethora of biochemical as well as cell biological processes, including glucose metabolism, apoptosis and angiogenesis. In melanoma, HIF-1alpha has been implicated in tumor progression with effects upon metastasis and angiogenesis. However, its role in malignant transformation by oncogenes has not been described. Bedogni et al. (Cancer Cell 2005, 8:443-54) report that the hypoxic microenvironment in the skin contributes to melanocyte transformation and tumor growth induced by oncogenes Ras and Akt, which are frequently activated in melanoma. HIF-1alpha activity was found to be required in Akt-induced melanocyte transformation and tumor growth and it was suppressed greatly by mTOR inhibition with rapamycin. Since mTOR regulates HIF-1alpha expression and its transcriptional activity, rapamycin was proposed as a promising hypoxia-related therapeutic approach in melanoma treatment. This study sheds light upon the role of HIF-1alpha in the early stage of melanoma development and highl...Continue Reading
Citations
Oct 11, 2011·Clinical & Experimental Metastasis·Alexandra GiatromanolakiMichael I Koukourakis
Dec 11, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yeqiang LiuYating Tu
Oct 18, 2008·The Journal of Clinical Investigation·Barbara BedogniMarianne Broome Powell
Apr 24, 2010·BMC Cancer·Kara C SedorisDonald M Miller
Mar 30, 2012·PloS One·Asunción Fernández-BarralBenilde Jiménez
Feb 27, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silke KuphalAnja-Katrin Bosserhoff
Jul 15, 2015·Biochimica Et Biophysica Acta·Anna HabrykaDorota Scieglinska
Apr 18, 2007·Experimental Dermatology·C T OngT T Phan
May 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shuixian LiXiuzhen Han
Dec 18, 2007·Seminars in Oncology·Ganapati H Mahabeleshwar, Tatiana V Byzova
Apr 20, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·YanHong YaoBaoGuo Li
Jan 15, 2014·Free Radical Biology & Medicine·Guei-Sheung LiuMing-Hong Tai
Feb 22, 2008·Journal of Biomedicine & Biotechnology·George A ThouasKerry Hourigan
Jul 8, 2014·Frontiers in Oncology·Brittany Anne DavidsonAngeles Alvarez Secord
Oct 28, 2014·PloS One·Donald J ScholtenMatthew R Steensma
Feb 13, 2016·Journal of Clinical Pathology·George JourPhyu P Aung
Aug 29, 2012·Molecular Pharmaceutics·Xi-Qiu LiuJun Wang
Mar 30, 2018·Plastic and Reconstructive Surgery·Andrea PaganiDominik Duscher
Dec 15, 2017·Cell Death & Disease·Daniela TrisciuoglioDonatella Del Bufalo
Apr 20, 2020·Journal of Cosmetic Dermatology·Dominik DuscherDominik Thor
Jun 2, 2020·Aesthetic Surgery Journal·Andrea PaganiDominik Duscher
Dec 31, 2014·World Journal of Gastroenterology : WJG·Na-Na TangRui-Hua Shi
Sep 9, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Norman Chan, Robert G Bristow
Oct 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peiwen ChenYongzhang Luo
Dec 24, 2011·Journal of Cell Science·Hamid Reza RezvaniFrédéric Mazurier
Jul 6, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mohammad MalekanFateme Sheida